tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

3 Best Stocks to Buy Now, 9/22/2025, According to Top Analysts

3 Best Stocks to Buy Now, 9/22/2025, According to Top Analysts

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well. 

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.

Praxis Precision Medicines (PRAX) – Praxis is a U.S. biopharma company that focuses on developing drugs for central nervous system diseases such as epilepsy and movement disorders. Today, TD Cowen analyst Ritu Baral reaffirmed her price target of $61 per share. Interestingly, of the nine Top analysts covering the stock, eight gave it a Buy rating, while one put forward a Sell recommendation. Taken together, their 12-month price target suggests a 160.31% upswing potential.

Global-e Online (GLBE) – This is an Israel-based e-commerce platform that enables shoppers and merchants to buy and sell internationally. Today, Benchmark Co. analyst Mark Zgutowicz kept the price target unchanged at $52 per share. In the last three months, the five Top analysts covering this stock have given it a Buy rating. Overall, their 12-month price target points to a 42.50% leap potential from the current level.

Super Group (SGHC) – This is a global gaming and online sports betting company based in Saint Peter Port in Guernsey, a British Crown Dependency located in the English Channel. Today, BTIG analyst Clark Lampen clung to his Buy rating for the stock, suggesting a price target of between $14 and $19 per share. In the last three months, all seven Top analysts covering this stock gave it a Buy rating. Altogether, their 12-month price target indicates a 32.50% growth potential.

Who Are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page. 

Disclaimer & DisclosureReport an Issue

1